Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Liabilities (2023 - 2024)

Contineum Therapeutics (CTNM) has 2 years of Other Non-Current Liabilities data on record, last reported at $228000.0 in Q1 2024.

  • For Q1 2024, Other Non-Current Liabilities changed N/A year-over-year to $228000.0; the TTM value through Mar 2024 reached $228000.0, changed N/A, while the annual FY2023 figure was $110000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $228000.0 in Q1 2024 per CTNM's latest filing, up from $110000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $228000.0 in Q1 2024 and bottomed at $110000.0 in Q4 2023.